静脈注射器市場- 世界の産業規模、シェア、動向、機会、予測、セグメントタイプ別、エンドユーザー別、地域別、競合、2020-2030F

静脈内（IV）装置の世界市場規模は2024年に135億7,000万米ドルとなり、2030年までのCAGRは5.27%で、予測期間中に力強い成長が予測されています。

世界の静脈内（IV）装置市場は、広範なヘルスケア産業の中でダイナミックかつ急速に発展している分野であり、患者のケアと治療において極めて重要な役割を果たしています。静脈内療法では、静脈を通じて血液の流れに直接、水分、薬物、栄養素を投与しますが、対応する機器には、このプロセスを促進するために設計されたさまざまな機器が含まれます。同市場は、慢性疾患の増加、高齢化、世界の外科手術件数の増加などを背景に、革新的かつ先進的な輸液機器への需要が高まっているのが特徴です。例えば、2021年4月に発表された世界保健機関（WHO）のデータによると、慢性疾患は年間4,100万人の死亡を引き起こし、世界の全死亡の71%を占めると予測されています。さらに、低・中所得国の死亡率の77％は慢性疾患に起因しています。がん患者やその他の慢性疾患の増加に伴い、様々な外科手術の需要が増加し、市場成長の原動力になると予想されます。

静脈注射器世界市場成長の主な要因には、糖尿病、がん、心血管障害などの疾病の発生率の上昇が含まれ、効率的で正確なドラッグデリバリー機構が必要とされています。世界中のヘルスケアシステムが患者の転帰を改善し、入院期間を最小限に抑えることに注力しているため、点滴療法の需要が急増しています。スマートポンプ、安全輸液システム、ワイヤレス接続などの点滴機器の技術進歩は、薬剤投与の正確性と安全性を高め、市場拡大をさらに後押ししています。

主な市場促進要因

慢性疾患の有病率の上昇

主な市場課題

コスト制約と手頃な価格

主な市場動向

患者中心のヘルスケアへの注力

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の静脈内（IV）機器市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（IVカテーテル、輸液ポンプ、固定装置、投与セット、点滴チャンバー、その他のタイプ）
  • エンドユーザー別（病院、外来手術センター、その他のエンドユーザー）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の静脈内（IV）機器市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の静脈内（IV）機器市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の静脈内（IV）機器市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の静脈内（IV）機器市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東およびアフリカの静脈内（IV）機器市場の見通し

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の静脈内（IV）機器市場： SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• 3D Systems, Inc.
• 3M Company
• Baxter International
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• EuroLife Healthcare Pvt. Ltd
• Henry Schein, Inc
• ICU Medical, Inc
• Polymedicure
• Terumo Corporation
• Teleflex Incorporated

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Intravenous (IV) Equipment Market was valued at USD 13.57 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.27% through 2030. The Global Intravenous (IV) Equipment Market is a dynamic and rapidly evolving sector within the broader healthcare industry, playing a pivotal role in patient care and treatment. Intravenous therapy involves the administration of fluids, medications, and nutrients directly into the bloodstream through a vein, and the corresponding equipment encompasses a wide range of devices designed to facilitate this process. The market is characterized by a growing demand for innovative and advanced IV equipment, driven by the increasing prevalence of chronic diseases, the aging population, and the rising number of surgical procedures globally. For instance, according to data from the World Health Organization published in April 2021, chronic diseases are projected to cause 41 million deaths annually, accounting for 71% of all global deaths. Additionally, 77% of mortality in low- and middle-income countries is attributed to chronic diseases. As the number of cancer cases and other chronic conditions rise, the demand for various surgical procedures is expected to increase, driving market growth.

Key factors contributing to the growth of the Global Intravenous Equipment Market include the escalating incidence of diseases such as diabetes, cancer, and cardiovascular disorders, necessitating efficient and precise drug delivery mechanisms. As healthcare systems worldwide focus on improving patient outcomes and minimizing hospital stays, the demand for intravenous therapies has surged. The technological advancements in IV equipment, such as smart pumps, safety infusion systems, and wireless connectivity, have enhanced the accuracy and safety of drug administration, further fueling market expansion.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a pivotal factor driving the robust growth of the Global Intravenous (IV) Equipment Market. Chronic diseases, including diabetes, cardiovascular disorders, and cancer, have witnessed a significant surge in incidence worldwide. These conditions often necessitate long-term and intricate medical interventions, with intravenous therapy emerging as a crucial component of their management. The prevalence of chronic diseases is influenced by factors such as sedentary lifestyles, aging populations, and changes in dietary habits. As a result, there is an escalating demand for advanced and efficient intravenous solutions and equipment to facilitate the administration of medications and fluids required for the treatment of chronic conditions. For instance, according to the Alzheimer Society of Canada, over 500,000 Canadians were living with dementia as of January 2021, with the number expected to increase to 912,000 by 2030. Similarly, the Fondation de France reported that around 150,000 people in France were affected by Parkinson's disease in 2021, with the disease predominantly impacting the elderly. As the prevalence of chronic diseases rises, the demand for related healthcare solutions is expected to drive market growth in the coming years.

Key Market Challenges

Cost Constraints and Affordability

Cost constraints and affordability represent significant hurdles for the Global Intravenous (IV) Equipment Market, posing challenges to the widespread adoption of advanced intravenous technologies. The intricate and innovative nature of modern IV equipment, including infusion pumps, smart catheters, and monitoring systems, often comes with a hefty price tag. This presents a barrier for healthcare facilities, particularly in resource-limited regions, where financial constraints impede the seamless integration of state-of-the-art IV solutions.

One of the primary obstacles is the high initial investment required for acquiring advanced IV equipment. Hospitals and healthcare providers, particularly those in developing countries, often operate on tight budgets, making it challenging to allocate substantial funds for the purchase of cutting-edge IV technologies. The upfront costs for these devices can strain financial resources, limiting the ability of healthcare facilities to invest in the latest innovations that could otherwise enhance patient care and safety.

Key Market Trends

Focus on Patient-Centric Healthcare

The Global Intravenous (IV) Equipment Market is experiencing a significant boost due to a pronounced shift towards patient-centric healthcare. This transformative trend places the patient at the center of the healthcare experience, influencing the design, functionality, and adoption of intravenous equipment. Recognizing the importance of patient comfort and adherence to treatment plans, manufacturers are increasingly prioritizing user-friendly features in the development of IV devices. Catheters, infusion pumps, and related accessories are being designed with a focus on minimizing discomfort, simplifying usage, and reducing the risk of complications.

Key Market Players

• 3D Systems, Inc.
• 3M Company
• Baxter International
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• EuroLife Healthcare Pvt. Ltd
• Henry Schein, Inc
• ICU Medical, Inc
• Polymedicure
• Terumo Corporation
• Teleflex Incorporated

Report Scope:

In this report, the Global Intravenous (IV) Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Equipment Market, By Type:

• IV Catheters
• Infusion Pumps
• Securement Devices
• Administration Sets
• Drip Chambers
• Other Types

Intravenous (IV) Equipment Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

Intravenous (IV) Equipment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Equipment Market.

Available Customizations:

Global Intravenous (IV) Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Intravenous (IV) Equipment Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (IV Catheters, Infusion Pumps, Securement Devices, Administration Sets, Drip Chambers, Other Types)
  • 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By End-User
  • 4.3.3. By Region

5. Asia Pacific Intravenous (IV) Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By End-User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Intravenous (IV) Equipment Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By End-User
  • 5.3.2. India Intravenous (IV) Equipment Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By End-User
  • 5.3.3. Australia Intravenous (IV) Equipment Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By End-User
  • 5.3.4. Japan Intravenous (IV) Equipment Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By End-User
  • 5.3.5. South Korea Intravenous (IV) Equipment Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By End-User

6. Europe Intravenous (IV) Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Intravenous (IV) Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End-User
  • 6.3.2. Germany Intravenous (IV) Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End-User
  • 6.3.3. Spain Intravenous (IV) Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End-User
  • 6.3.4. Italy Intravenous (IV) Equipment Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By End-User
  • 6.3.5. United Kingdom Intravenous (IV) Equipment Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By End-User

7. North America Intravenous (IV) Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Intravenous (IV) Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End-User
  • 7.3.2. Mexico Intravenous (IV) Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End-User
  • 7.3.3. Canada Intravenous (IV) Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End-User

8. South America Intravenous (IV) Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Intravenous (IV) Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End-User
  • 8.3.2. Argentina Intravenous (IV) Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End-User
  • 8.3.3. Colombia Intravenous (IV) Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End-User

9. Middle East and Africa Intravenous (IV) Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Intravenous (IV) Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End-User
  • 9.3.2. Saudi Arabia Intravenous (IV) Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End-User
  • 9.3.3. UAE Intravenous (IV) Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End-User
  • 9.3.4. Egypt Intravenous (IV) Equipment Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Intravenous (IV) Equipment Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. 3D Systems, Inc.
  • 14.1.1. Company Snapshot
  • 14.1.2. Products & Services
  • 14.1.3. Current Capacity Analysis
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. 3M Company
• 14.3. Baxter International
• 14.4. Becton, Dickinson and Company
• 14.5. B. Braun Melsungen AG
• 14.6. EuroLife Healthcare Pvt. Ltd
• 14.7. Henry Schein, Inc
• 14.8. ICU Medical, Inc
• 14.9. Polymedicure
• 14.10.Terumo Corporation
• 14.11.Teleflex Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer